22 February 2022 · Transcribing is not the preferred option for medicines administration and the alternatives should be considered before committing to transcribing.
1 March 2022 · National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines
9 September 2020 · This article provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD
22 February 2022 · Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input
16 September 2022 · A summary of the implications of the UKs exit from the EU for clinical trial sites for both IMP and ATIMPs, including supply to and from Northern Ireland